Emergent BioSolutions

Work in HR? Unlock Free Profile

Emergent BioSolutions Reviews

42 Reviews
42 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Emergent BioSolutions President & CEO Daniel J. Abdun-Nabi
Daniel J. Abdun-Nabi
14 Ratings

    Great Company Great Employees

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Current Employee - Assistant Scientist  in  Baltimore, MD
    Current Employee - Assistant Scientist in Baltimore, MD

    I have been working at Emergent BioSolutions full-time for less than a year


    Training is good, focused on continuous improvement


    Upward mobility is difficult. Shy to promote from within.

    Positive Outlook
    Approves of CEO

Emergent BioSolutions Interviews

Updated Sep 10, 2014
Updated Sep 10, 2014

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty




    Manager, PM Corporate Projects Interview

    Anonymous Employee  in  Rockville, MD
    Anonymous Employee in Rockville, MD
    Application Details

    I applied online. The process took 3 weeks - interviewed at Emergent BioSolutions in July 2014.

    Interview Details

    Quick contact by HR after applying on-line. Quick progression to on-site interview. Horrible follow-up. Despite several attempts to get a status update. Simply no communication was made. You should ask yourself, do you really want to work for a company that treats interview candidates like that?

    Interview Questions
    No Offer
    Negative Experience
    Easy Interview

Emergent BioSolutions Awards & Accolades

Something missing? Add an award
America's 200 Best Small Companies, Forbes, 2009

Additional Info

Unlock Profile
Website www.emergentbiosolutions.com
Headquarters Rockville, MD
Size 1000 to 5000 Employees
Founded 1998
Type Company - Public (EBS)
Industry Biotech & Pharmaceuticals
Revenue $100 to $500 million (USD) per year

Emergent BioSolutions protects your thorax against anthrax. The company develops and produces vaccines that treat or protect against infectious diseases and bio-agents. The company supplies BioThrax (the US's only FDA-approved anthrax vaccine) primarily to the departments of Defense and Health and Human Services (HHS). Its biodefense unit is also developing a post-exposure treatment for anthrax and a preventive vaccine for botulinum toxin. For commercial markets, Emergent BioSolutions is working on therapies and vaccines for such infectious diseases as typhoid... More

Worked for Emergent BioSolutions? Contribute to the Community!